The value and limitations of long-term nucleoside antiviral therapy in chronic hepatitis B

被引:5
|
作者
Dienstag, JL
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit,Med Serv, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA
关键词
D O I
10.1016/j.jhep.2004.12.001
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:158 / 162
页数:5
相关论文
共 50 条
  • [41] Hepatitis B virus (HBV) mutations during long-term therapy in chronic hepatitis B patients
    Arrese, E.
    Basaras, M.
    Blanco, S.
    Ruiz, P.
    Cisterna, R.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : E233 - E234
  • [42] Impact of steatosis on long-term histological outcome in chronic hepatitis C after antiviral therapy
    Hung, Chao-Hung
    Kuo, Fang-Ying
    Wang, Jing-Houng
    Lu, Sheng-Nan
    Hu, Tsung-Hui
    Chen, Chien-Hung
    Lee, Chuan-Mo
    Eng, Hock-Liew
    ANTIVIRAL THERAPY, 2006, 11 (04) : 483 - 489
  • [43] What is the Long-term Benefit of Direct-acting Antiviral Therapy in Chronic Hepatitis C?
    Kim, Jin-Wook
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2019, 34 (41)
  • [44] Efficacy of long-term tenofovir-based rescue therapy in patients with chronic hepatitis B refractory to nucleoside/nucleotide analogs
    Suzuki, Fumitaka
    Suzuki, Yoshiyuki
    Hosaka, Tetsuya
    Sezaki, Hitomi
    Akuta, Norio
    Fujiyama, Shunichiro
    Kawamura, Yusuke
    Kobayashi, Masahiro
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kobayashi, Mariko
    Mineta, Rie
    Suzuki, Yukiko
    Kumada, Hiromitsu
    JOURNAL OF GASTROENTEROLOGY, 2017, 52 (05) : 641 - 651
  • [45] Efficacy of long-term tenofovir-based rescue therapy in patients with chronic hepatitis B refractory to nucleoside/nucleotide analogs
    Fumitaka Suzuki
    Yoshiyuki Suzuki
    Tetsuya Hosaka
    Hitomi Sezaki
    Norio Akuta
    Shunichiro Fujiyama
    Yusuke Kawamura
    Masahiro Kobayashi
    Satoshi Saitoh
    Yasuji Arase
    Kenji Ikeda
    Mariko Kobayashi
    Rie Mineta
    Yukiko Suzuki
    Hiromitsu Kumada
    Journal of Gastroenterology, 2017, 52 : 641 - 651
  • [46] Long-term treatment outcomes of clevudine in antiviral-naive patients with chronic hepatitis B
    Suk Bae Kim
    Il Han Song
    Young Min Kim
    Ran Noh
    Ha Yan Kang
    Hyang Ie Lee
    Hyeon Yoong Yang
    An Na Kim
    Hee Bok Chae
    Sae Hwan Lee
    Hong Soo Kim
    Tae Hee Lee
    Young Woo Kang
    Eaum Seok Lee
    Seok Hyun Kim
    Byung Seok Lee
    Heon Young Lee
    World Journal of Gastroenterology, 2012, (47) : 6943 - 6950
  • [47] Antiviral Therapy of Chronic Hepatitis B
    van Boemmel, Florian
    Berg, Thomas
    INTERVIROLOGY, 2014, 57 (3-4) : 171 - 180
  • [48] Body-mass index is associated with fibrosis regression during long-term nucleoside analogue therapy in chronic hepatitis B
    Seto, W. -K.
    Fung, J.
    Cheung, K. -S.
    Mak, L. -Y.
    Hui, R. W. H.
    Liu, K. S. H.
    Lai, C. -L.
    Yuen, M. -F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (10) : 1071 - 1079
  • [49] Long-term treatment outcomes of clevudine in antiviral-naive patients with chronic hepatitis B
    Kim, Suk Bae
    Song, Il Han
    Kim, Young Min
    Noh, Ran
    Kang, Ha Yan
    Lee, Hyang Ie
    Yang, Hyeon Yoong
    Kim, An Na
    Chae, Hee Bok
    Lee, Sae Hwan
    Kim, Hong Soo
    Lee, Tae Hee
    Kang, Young Woo
    Lee, Eaum Seok
    Kim, Seok Hyun
    Lee, Byung Seok
    Lee, Heon Young
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (47) : 6943 - 6950
  • [50] Antiviral therapy of chronic hepatitis B
    Zoulim, Fabien
    ANTIVIRAL RESEARCH, 2006, 71 (2-3) : 206 - 215